Jump Financial’s Arcadia Biosciences RKDA Stock Holding History

Jump Financial’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.8K	Buy	+24,301	New	+$13.5K	﹤0.01%	2260

Other funds holding RKDA

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BWM

Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Jump Financial's RKDA Position: Q3 2026 in Review

Jump Financial opened a new position in Arcadia Biosciences (RKDA) in Q3 2026: 24,301 shares worth $6.8K. The stake represents ﹤0.01% of the portfolio and ranks #2260 among its holdings.

15 funds tracked by Wall St. Rank hold RKDA as of Q3 2026.

Jump Financial held 24,301 shares of Arcadia Biosciences worth $6.8K as of Q3 2026.
Arcadia Biosciences was a new Jump Financial position in Q3 2026.
Arcadia Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2260 holding.
15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.